Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Pharmacotherapy in Obesity: Intermittent Phentermine Improves Visceral Adiposity and Body Composition

NCT07870668 is registered in ClinicalTrials.gov with OSCAR MANUEL TORRES FALCON as lead sponsor.

NCT NCT07870668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07870668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Pharmacotherapy in Obesity: Intermittent Phentermine Improves Visceral Adiposity and Body Composition
Lead sponsor
OSCAR MANUEL TORRES FALCON
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2024
Completion date
January 15, 2026
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight